FDA Clearance Tracker · K221817
ALFIS Vitamin D, ALFIS-3 Analyzer
Last checked: Nov 19, 2026Latest source record: Sep 22, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 22, 2023
Substantially Equivalent
Time to decision
457 days
Received Jun 22, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K221817
- Device name
- ALFIS Vitamin D, ALFIS-3 Analyzer
- Applicant
- Immunostics Inc.,
- Applicant location
- Eatontown, NJ
- Received
- Jun 22, 2022
- Decided
- Sep 22, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- System, Test, Vitamin D (MRG)
- Device class
- Class II
- Regulation
- 21 CFR 862.1825
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MRG. The earliest in FDA's data is K953567, decided Sep 25, 1996.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K221817
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Immunostics Inc.,
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- hemochroma PLUS System510(k)
K182298 · Decided Nov 16, 2018 · 84 days after receipt
Device type: System, Hemoglobin, Automated (GKR) · Laboratory Medicine & Pathology
- hemochroma PLUS System510(k)
K163465 · Decided Sep 8, 2017 · 270 days after receipt
Device type: System, Hemoglobin, Automated (GKR) · Laboratory Medicine & Pathology
- AFIAS iFOB with AFIAS-50510(k)
K163225 · Decided Aug 8, 2017 · 264 days after receipt
Device type: Automated Occult Blood Analyzer (OOX) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.